1 | hypertension | 28,644 |
2 | sarcoidosis | 349 |
3 | blepharospasm | 65 |
4 | thrombocythemia | 60 |
5 | cryptococcosis | 48 |
6 | thrombocythaemia | 41 |
7 | blastomycosis | 26 |
8 | ureterolithiasis | 13 |
9 | microhemorrhages | 9 |
10 | g361 | 7 |
11 | emptiness | 6 |
12 | hypotensives | 6 |
13 | sarcoglycanopathy | 6 |
14 | hetacillin | 5 |
15 | lactatemia | 5 |
16 | leishmaniases | 5 |
17 | pasteurellosis | 5 |
18 | po₂ | 5 |
19 | leukostasis | 4 |
20 | lubeluzole | 4 |
21 | shigellae | 4 |
22 | anti-retrovirals | 3 |
23 | cam2028 | 3 |
24 | chemotherapeutically | 3 |
25 | dextrocardia | 3 |
26 | healthcare- | 3 |
27 | hyper-tension | 3 |
28 | lipoidoproteinosis | 3 |
29 | myopericytoma | 3 |
30 | nmcs | 3 |
31 | tihap650 | 3 |
32 | valvectomy | 3 |
33 | vindesine-cisplatin | 3 |
34 | gdd/id | 2 |
35 | hypertension-2 | 2 |
36 | inflammation | 2 |
37 | mhbps | 2 |
38 | micro-calcification | 2 |
39 | nodules/masses | 2 |
40 | nutrients/minerals | 2 |
41 | rtd/pla | 2 |
42 | v179d/e/t | 2 |
43 | absorbant | 1 |
44 | asthma.we | 1 |
45 | diarrhea.cross-reactivity | 1 |
46 | dwd1 | 1 |
47 | epinephritis | 1 |
48 | fat-embolism | 1 |
49 | hct116/oxpt | 1 |
50 | hypertension/eclampsia | 1 |
51 | macro-reentry | 1 |
52 | patients-that | 1 |
53 | subjects.it | 1 |
54 | sulfidization | 1 |
55 | technique.eight | 1 |
56 | technique.seven | 1 |
1 | absorbant | 1 |
2 | anti-retrovirals | 3 |
3 | asthma.we | 1 |
4 | blastomycosis | 26 |
5 | blepharospasm | 65 |
6 | cam2028 | 3 |
7 | chemotherapeutically | 3 |
8 | cryptococcosis | 48 |
9 | dextrocardia | 3 |
10 | diarrhea.cross-reactivity | 1 |
11 | dwd1 | 1 |
12 | emptiness | 6 |
13 | epinephritis | 1 |
14 | fat-embolism | 1 |
15 | g361 | 7 |
16 | gdd/id | 2 |
17 | hct116/oxpt | 1 |
18 | healthcare- | 3 |
19 | hetacillin | 5 |
20 | hyper-tension | 3 |
21 | hypertension | 28,644 |
22 | hypertension-2 | 2 |
23 | hypertension/eclampsia | 1 |
24 | hypotensives | 6 |
25 | inflammation | 2 |
26 | lactatemia | 5 |
27 | leishmaniases | 5 |
28 | leukostasis | 4 |
29 | lipoidoproteinosis | 3 |
30 | lubeluzole | 4 |
31 | macro-reentry | 1 |
32 | mhbps | 2 |
33 | micro-calcification | 2 |
34 | microhemorrhages | 9 |
35 | myopericytoma | 3 |
36 | nmcs | 3 |
37 | nodules/masses | 2 |
38 | nutrients/minerals | 2 |
39 | pasteurellosis | 5 |
40 | patients-that | 1 |
41 | po₂ | 5 |
42 | rtd/pla | 2 |
43 | sarcoglycanopathy | 6 |
44 | sarcoidosis | 349 |
45 | shigellae | 4 |
46 | subjects.it | 1 |
47 | sulfidization | 1 |
48 | technique.eight | 1 |
49 | technique.seven | 1 |
50 | thrombocythaemia | 41 |
51 | thrombocythemia | 60 |
52 | tihap650 | 3 |
53 | ureterolithiasis | 13 |
54 | v179d/e/t | 2 |
55 | valvectomy | 3 |
56 | vindesine-cisplatin | 3 |
1 | healthcare- | 3 |
2 | tihap650 | 3 |
3 | g361 | 7 |
4 | dwd1 | 1 |
5 | hypertension-2 | 2 |
6 | cam2028 | 3 |
7 | dextrocardia | 3 |
8 | thrombocythaemia | 41 |
9 | thrombocythemia | 60 |
10 | lactatemia | 5 |
11 | hypertension/eclampsia | 1 |
12 | rtd/pla | 2 |
13 | myopericytoma | 3 |
14 | gdd/id | 2 |
15 | shigellae | 4 |
16 | lubeluzole | 4 |
17 | asthma.we | 1 |
18 | blepharospasm | 65 |
19 | fat-embolism | 1 |
20 | technique.seven | 1 |
21 | hetacillin | 5 |
22 | vindesine-cisplatin | 3 |
23 | hyper-tension | 3 |
24 | hypertension | 28,644 |
25 | micro-calcification | 2 |
26 | inflammation | 2 |
27 | sulfidization | 1 |
28 | nmcs | 3 |
29 | microhemorrhages | 9 |
30 | leishmaniases | 5 |
31 | nodules/masses | 2 |
32 | hypotensives | 6 |
33 | ureterolithiasis | 13 |
34 | leukostasis | 4 |
35 | cryptococcosis | 48 |
36 | blastomycosis | 26 |
37 | sarcoidosis | 349 |
38 | pasteurellosis | 5 |
39 | lipoidoproteinosis | 3 |
40 | epinephritis | 1 |
41 | nutrients/minerals | 2 |
42 | anti-retrovirals | 3 |
43 | mhbps | 2 |
44 | emptiness | 6 |
45 | v179d/e/t | 2 |
46 | patients-that | 1 |
47 | technique.eight | 1 |
48 | subjects.it | 1 |
49 | absorbant | 1 |
50 | hct116/oxpt | 1 |
51 | sarcoglycanopathy | 6 |
52 | chemotherapeutically | 3 |
53 | valvectomy | 3 |
54 | macro-reentry | 1 |
55 | diarrhea.cross-reactivity | 1 |
56 | po₂ | 5 |